Greater Impact of Living Donation Than HLA Mismatching in Short-Term Renal Allograft Survival

Introduction: Living donor kidney transplantation (LDKT) is accepted as first-line treatment for patients with end-stage kidney disease with advantages over deceased donor kidney transplantation (DDKT). Still, how the known detrimental effect of HLA mismatch (MM) may hamper these advantages remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Bárbara, Reis Pereira, Pedro, Oliveira, João, Almeida, Manuela, Martins, La Salete, Malheiro, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887496/
https://www.ncbi.nlm.nih.gov/pubmed/36733571
http://dx.doi.org/10.7759/cureus.34427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887496/
https://www.ncbi.nlm.nih.gov/pubmed/36733571
http://dx.doi.org/10.7759/cureus.34427

Ejemplares similares